A Careful Eye Needed To Spot Growth Opportunities This Year In Southeast Asia
This article was originally published in PharmAsia News
Executive Summary
Major drug companies face high hurdles in Southeast Asian nations – even where reimbursement programs are growing and governments are eager to attract direct investment.